Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs

Go back to Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) Delayed: 6.30 -0.19 (2.93%)
Previous Close $6.49    52 Week High $11.69 
Open $6.58    52 Week Low $4.50 
Day High $6.60    P/E N/A 
Day Low $6.23    EPS $-0.28 
Volume 3,036,549